¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Placental disorder, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
¿µ¹® affective disorder ÇÑ±Û Á¤µ¿Àå¾Ö
¼³¸í   
  ÁַΠ±âºÐÀÇ Àå¾Ö°¡ ÁÖÃàÀÌ µÇ´Â ÀÏ·ÃÀÇ Á¤½ÅÀå¾ÖÀÌ´Ù. ÀÌ º´ÀÇ ¹üÁÖ¿¡´Â(¿ì¿ïº´£­Áö¼ÓÀûÀ¸·Î ¿ì¿ïÇÑ ±âºÐÀÌ ¿ÜºÎÀڱذú °ü°è¾øÀÌ ³ªÅ¸³ª´Â º´), (Á¶º´£­Áö¼ÓÀûÀ¸·Î µé¶á ±âºÐÀÌ ¿ÜºÎÀڱذú °ü°è¾øÀÌ °è¼ÓµÇ´Â º´) µîÀÌ Æ÷ÇԵȴÙ.
¿µ¹® psychiatric disorder(s) ÇÑ±Û Á¤½ÅÁúȯ
¼³¸í   
  Á¤½Å»óÅ¿¡ ÀÌ»óÀÌ Àִ ÁúȯÀ¸·Î, Á¤½ÅºÐ¿­º´, Á¤µ¿Àå¾Ö, ÀΰÝÀå¾Ö µîÀÌ ÀÖ´Ù.
¿µ¹® learning disorder ÇÑ±Û ÇнÀÀå¾Ö
¼³¸í   
  Áö´ÉÀº Á¤»óÀÌÁö¸¸ µè±â, ¸»Çϱâ, Àбâ, ¾²±â, Ã߸® ¶Ç´Â °è»ê´É·Â¿¡ ½É°¢ÇÑ ¹®Á¦°¡ ³ªÅ¸³ª´Â ¿©·¯ Àå¾ÖµéÀ» ÀÏÄ´ ¿ë¾î. À̷ΠÀÎÇØ Çо÷¼ºÀû ¹× Àڽۨ ÀúÇÏ, ´ëÀΰü°è¿¡¼­µµ »ç±³ ´É·ÂÀÌ ¹Ì¼÷ÇÏ¿© ÀÏ»ó»ýȰÀÇ ¸ðµç ¸é¿¡¼­ ¹®Á¦°¡ ³ªÅ¸³­´Ù. ¼ºÀα⠻çȸÀûÀÀ·Â¿¡µµ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¸ç, ÇൿÀå¾Ö, ÁÖÀǷ°áÇÌ, °úÀ׿Àå¾Ö, ¿ì¿ïÀå¾Ö µî°ú µ¿¹ÝµÇ¾î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ±× À¯º´·üÀº ³·°Ô´Â 1.7%, ³ô°Ô´Â 30% Á¤µµ·Î ÃßÁ¤Çϰí ÀÖÁö¸¸ Çе¿±â ¾Æµ¿ÀÇ ¾à 3~9%°¡ ÀÌ Àå¾Ö¸¦ °®°í Àִ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ±âÃÊÇнÀ±â´É°Ë»ç¸¦ ÅëÇÏ¿© Áø´ÜÇÑ´Ù. ÇнÀÀÇ ±âȸ³ª ±³À°ÀûÀΠÀÚ±ØÀÌ ºÎÁ·ÇÑ °æ¿ì, ÁýÁ߷ ºÎÁ·, ¿ì¿ïÁõ-ºÒ¾È µî Á¤¼­Àû ¹®Á¦, ½Å°æÇÐÀû À̻󿡠ÀÇÇÑ °æ¿ì µîÀÌ ¿øÀÎÀÏ ¼ö ÀÖ´Ù. ÇнÀ°ú °ü·ÃÀÌ Àִ ³ú±â´É°ú ¿¬°üµÈ Æ¯Á¤¿µ¿ª¿¡ °áÇÔÀÌ Àְųª ¹ßÀ°Áö¿¬ ¶Ç´Â Àå¾Ö°¡ Àִ °æ¿ìµµ ¿øÀÎÀÌ µÈ´Ù. ¶ÇÇÑ ºÎ¸ð°¡ Á¶±â¿¡ ÀÚ³àÀÇ ´É·Â°ú Àû¼ºÀ» Àß ¾ËÁö ¸øÇϴ °æ¿ì¿¡µµ ¸¹ÀÌ »ý±ä´Ù.
¿µ¹® dissociative disorder ÇÑ±Û ÇØ¸®Àå¾Ö
¼³¸í   
  ÀǽÄ, µ¿ÀÛ, È¤Àº ÁÖü¼º µîÀÇ ÀΰÝÀÇ Á¤»óÀûÀΠÅëÇÕ±â´É¿¡ ±Þ°ÝÇϰí ÀϽÃÀûÀΠº¯È­°¡ ÀϾ¼­ Çϳª, ¶Ç´Â ±× ÀÌ»óÀÇ ±â´ÉÀÇ ¾î´À ºÎºÐÀÌ »ó½ÇµÇ´Â Á¤½ÅÁúȯÀ» Çظ®¼º Àå¾Ö¶ó°í ÇÑ´Ù. ÀÌ Áúȯ¿¡ ¼ÓÇϴ ´ëÇ¥ÀûÀΠ°ÍÀ¸·Î´Â ½ÉÀμº±â¾ï»ó½ÇÁõ(psychogenic amnesia), ´ÙÁßÀΰÝ(multiple personality), µÐÁÖ(fugue) µîÀÌ ÀÖ´Ù. ½ÉÀμº ±â¾ï»ó½ÇÁõÀ̶õ Á¤½ÅÀûÀΠÅëÇÕ±â´É Áß¿¡¼­ Æ¯È÷ ÀǽÄÀÇ ±Þ°ÝÇϰí ÀϽÃÀûÀΠº¯È­°¡ ÀϾ¼­ ³úÀÇ Àå¾Ö¾øÀÌ °ú°ÅÀÇ ÀÏÀ» ±â¾ïÇÏÁö ¸øÇϴ °ÍÀ» ¸»ÇÑ´Ù. ´ÙÁßÀΰÝÀ̶õ ÇÑ °¡Áö ÀÌ»óÀÇ ÀΰÝÀÌ »ç¶÷¿¡°Ô Á¸ÀçÇϴ °ÍÀ¸·Î Æ¯Á¤ÇÑ ÀΰÝÀº ÀÏÁ¤ ±â°£µ¿¾È ±× »ç¶÷À» Áö¹èÇÏ°í ±× Àΰݠ°¢°¢Àº ±× ³ª¸§ÀǠü°è¸¦ °¡Áö°í Àΰ£°ü°è¸¦ Çü¼ºÇϴ °ÍÀÌ ´ëºÎºÐÀÌ´Ù. µÐÁÖ¶õ ÀÚ½ÅÀÇ ÁÖü¿¡ ´ëÇÑ ±â¾ïÀ» »ó½ÇÇÏ°í »õ·Î¿î ÁÖü¼ºÀ» °¡Áö°í °¡Á¤À̳ª Á÷ÀåÀ» ¶°³ª¼­ ¿¹Á¤¿¡ ¾ø´ø ¿©ÇàÀ» °©ÀÛ½º·´°Ô Çϴ °ÍÀ¸·Î ´ë°³ Åë»óÀûÀΠ»óȲ¿¡¼­´Â °ÅÀÇ ÀϾÁö ¾Ê°í Àü½Ã, ÃµÀçÁöº¯¿¡¼­ ÀÚÁÖ ÀÖ°í µÐÁÖ¿¡¼­ÀǠȸº¹Àº ±ÞÀÛ½º·´°Ô ÀϾ°í Àç¹ßÀº °ÅÀÇ ¾ø´Ù. Çظ®¼º Àå¾ÖÀÇ ´ëºÎºÐÀº È¸º¹ÀÌ µÉ °æ¿ì¿¡´Â ¹ßº´±â°£ Áß¿¡ ÀÖ¾ú´ø ÀÏÀ» ±â¾ïÇØ ³»Áö ¸øÇϴ °ÍÀÌ ´ëºÎºÐÀÌ´Ù.
¿µ¹® behavior disorder ÇÑ±Û ÇൿÀå¾Ö
¼³¸í   
  Á¤½ÅÀå¾Ö¸¦ °¡¸®Å°´Âµ¥ »ç¿ëµÇ´Â ¿ë¾î·Î¼­, Æ¯È÷ ÁöÀû, °¨Á¤Àû, ÇൿÀû Á¤½ÅÀå¾ÖÀ̸ç, ±âÁúÀû Àå¾Ö°¡ À־ »ý±â´Â °ÍÀº ¾Æ´Ï´Ù. Áö¼ÓÀûÀ¸·Î Å¸ÀÎÀÇ ±Ç¸®¸¦ Ä§¹üÇϰųª ³ªÀÌ¿¡ °É¸ÂÁö ¾Ê°Ô »çȸÀû ±Ô¹üÀ» ¾î±â´Â ÇൿÀÌ ³ªÅ¸³ª´Â Àå¾Ö·Î¼­, µµ½Ã¿¡¼­ ´õ ¸¹ÀÌ ³ªÅ¸³ª´Â °æÇâÀÌ ÀÖ´Ù. Á¤½ÅºÐ¼®ÇÐÀûÀΠ°ßÇØ¿¡ ÀÇÇϸ頵µ´öÀû ÃÊÀھư¡ ¼ºÀåÇÏÁö ¸øÇÏ¿© ³ªÅ¸³ª°Å³ª ºÎ¸ðÀÇ ¹«ÀǽÄÀûÀÌ°í ¹Ý»çȸÀû Ã浿ÀÌ ¾î¸°ÀÌ¿¡°Ô Àü´ÞµÇ¾î ÇൿȭÇϴ °ÍÀ̶ó°í ÇÑ´Ù. °¡Á¤È¯°æÀû ¿øÀÎÀ¸·Î´Â °á¼Õ°¡Á¤, ºÎ¸ðÀÇ °¥µî, ¾ËÄڿàÁßµ¶, ¾à¹°³²¿ë, ¹Ý»çȸÀû Çൿ µîÀ» µ¿¹ÝÇÑ ¾Æ¹öÁöÀÇ Á¤½Åº´¸®, Àϰü¼º ¾ø´Â ÈÆÀ°, ¾Æµ¿Çдë, ¾î¸Ó´ÏÀÇ ¿ì¿ïÁõ µîÀ» µé ¼ö ÀÖ´Ù. »ý¹°ÇÐÀû ¿äÀÎÀ¸·Î´Â À¯ÀüÀûÀ¸·Î Æ¯Á¤ À¯ÀüÁúº´À» ¾Î´Â È¯ÀÚÀÇ °æ¿ì¿¡ Æø·Â¼ºÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³ª´Â °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ°í, ³ú¼Õ»ó°ú ³úÆÄ ÀÌ»ó, °æ¹ÌÇÑ ½Å°æÇÐÀû ÀÌ»ó, È£¸£¸ó ºÒ±ÕÇü µîµµ ±× ¿øÀÎÀÌ µÇ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ÀÌ Àå¾Ö´Â ´ëºÎºÐ ÇнÀÀå¾Ö, ÁÖÀǷ °áÇÌ, °úÀ׿Àå¾Ö, ¿ì¿ïÀå¾Ö, ºÒ¾ÈÀå¾Ö, ¾à¹°³²¿ë µî°ú ÇÔ²² ³ªÅ¸³­´Ù. ¹Ì±¹ÀÇ Åë°è¿¡ ÀÇÇϸé 18¼¼ ÀÌÇÏÀÇ ³²¼º 6~16%, ¿©¼º 2~9%°¡ ÀÌ Àå¾Ö¸¦ °¡Áö°í Àִ °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ´Ù. Çѱ¹ÀÇ °æ¿ì ÃʵîÇб³ 4~6Çг⠾ÀÌ Áß ³²¾Æ 5%, ¿©¾Æ 2.3%°¡ ÀÌ Àå¾Ö¸¦ °¡Áö°í Àִ °ÍÀ¸·Î º¸°íµÇ¾ú´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • bipolar disorder
    ¾ç±Ø¼ºÀå¾Ö
  • body dysmorphic disorder
    ½ÅüÃßÇüÀå¾Ö
  • borderline personality disorder
    °æ°èÀΰÝÀå¾Ö
  • breathing related sleep disorder
    È£Èí°ü·Ã¼ö¸éÀå¾Ö
  • circadian rhythm sleep disorder
    ÇÏ·çÁÖ±âÀ²µ¿¼ö¸éÀå¾Ö, ÀÏÁÖ±âÀ²µ¿¼ö¸éÀå¾Ö
  • coagulation disorder
    ÀÀ°íÀå¾Ö
  • cognitive disorder
    ÀÎÁöÀå¾Ö
  • communication disorder
    ÀÇ»ç¼ÒÅëÀå¾Ö
  • compulsive personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • conduct disorder
    ÇൿÀå¾Ö
  • conversion disorder
    ÀüȯÀå¾Ö
  • coordination disorder
    Çùµ¿Àå¾Ö
  • cumulative trauma disorder
    ´©Àû¿Ü»óÀå¾Ö
  • cyclothymic disorder
    ¼øÈ¯±âºÐÀå¾Ö
  • central auditory processing disorder
    ÁßÃßû°¢Ã³¸®Àå¾Ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • psychogenic disorder
    Á¤½ÅÅ¿Àå¾Ö, ½ÉÀμºÀå¾Ö
  • reading disorder
    ÀбâÀå¾Ö
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
  • schizophreniform disorder
    Á¤½ÅºÐ¿­ÇüÀå¾Ö, Á¤½ÅºÐ¿­Çüº´
  • seizure disorder
    ¹ßÀÛÀå¾Ö
  • sexual disorder
    ¼ºÀå¾Ö
  • somatic disorder
    ½ÅüÀå¾Ö
  • somatization disorder
    ½ÅüȭÀå¾Ö
  • somatoform disorder
    ½ÅüÇüÀå¾Ö, ½ÅüÇüº´
  • sweating disorder
    ¶¡Àå¾Ö
  • thought disorder
    »ý°¢Àå¾Ö, »ç°íÀå¾Ö
  • vascular disorder
    Ç÷°üÁúȯ, Ç÷°üÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • chromosomal disorder
    ¿°»öüÀå¾Ö
  • chronic myeloproliferative disorder
    ¸¸¼º°ñ¼öÁõ½ÄÁúȯ
  • circadian rhythm sleep disorder
    ÀÏÁÖ±âÀ²µ¿¼ö¸éÀå¾Ö, ÇÏ·çÁÖ±â¼ö¸éÀå¾Ö
  • coagulation disorder
    ÀÀ°íÀå¾Ö
  • cognitive disorder
    ÀÎÁöÀå¾Ö
  • communication disorder
    ÀÇ»ç¼ÒÅëÀå¾Ö
  • compulsive personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • conduct disorder
    Çà½ÇÀå¾Ö, Çà½Çº´
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • conversion voice disorder
    ÀüȯÀ½¼ºÀå¾Ö
  • coordination disorder
    ÇùÀÀÀå¾Ö
  • cutaneous disorder
    ÇǺÎÁúȯ
  • cyclothymic disorder
    ¼øÈ¯¼º±âºÐÀå¾Ö
  • disorder
    Àå¾Ö, Áúȯ
  • delusional disorder
    ¸Á»óÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • placental membrane
    Źݸ·(¡­Ø¯).
  • placental mosaicism
    ŹÝ(÷ÃÚï)¸ðÀÚÀÌŰÁò
  • placental phase
    Źݱâ
  • placental pole
    ŹݱØ(¡­Ð¿).
  • placental polyp
    ÅÂ¹ÝÆú¸³, ŹݿëÁ¾.
  • placental polyp
    ŹÝ(÷ÃÚï)Æú¸³
  • placental septum
    ŹÝÁß°Ý(¡­ñḛ́).
  • placental site trophoblastic tumor
    ŹݺÎÂøºÎÀ§ À¶¸ð»óÇǼºÁ¾¾ç
  • placental souffle
    ŹÝÀâÀ½(¡­íÚëå).
  • placental souffle
    ŹÝÀâÀ½(÷ÃÚïíÚëå)
  • placental space
    Źݰ­(¡­Ë·).
  • placental stage
    Źݱâ(¡­Ñ¢).
  • placental thrombosis
    ŹÝÇ÷ÀüÁõ(÷ÃÚïúìîûñø)
  • placental tissue
    ŹÝÁ¶Á÷.
  • placental transfer
    ŹÝÀ̵¿.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • placental infection
    Źݰ¨¿°(¡­Êïæø).
  • placental insufficiency
    ŹݺÎÀü(Áõ)(÷ÃÚïÝÕîï(ñø))
  • placental insufficiency
    Źݱâ´ÉºÎÀü
  • placental lactogen
    Źݼº ¶ôÅä°Õ.
  • placental lactogen
    ÅÂ¹Ý ¶ôÅäÀü.
  • placental membrane
    Źݸ·(¡­Ø¯).
  • placental mosaicism
    ŹÝ(÷ÃÚï)¸ðÀÚÀÌŰÁò
  • placental phase
    Źݱâ
  • placental pole
    ŹݱØ(¡­Ð¿).
  • placental polyp
    ÅÂ¹ÝÆú¸³, ŹݿëÁ¾.
  • placental polyp
    ŹÝ(÷ÃÚï)Æú¸³
  • placental septum
    ŹÝÁß°Ý(¡­ñḛ́).
  • placental site trophoblastic tumor
    ŹݺÎÂøºÎÀ§ À¶¸ð»óÇǼºÁ¾¾ç
  • placental souffle
    ŹÝÀâÀ½(¡­íÚëå).
  • placental souffle
    ŹÝÀâÀ½(÷ÃÚïíÚëå)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
UPI Utero-Placental Insufficiency
ALPP alkaline phosphatase, placental
ALPPL alkaline phosphatase-like, placental
CPL caprine placental lactogen; conditioned pitch level; congenital pulmonary lymphangiectasia
HPL human parotid lysozyme; human peripheral lymphocyte; human placental lactogen
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PRI Placental Ribonuclease Inhibitor
P-ALP Placental alkaline phosphatase
PLF Placental isoferritin
PL-I Placental lactogen-I
P-LAP Placental leucine aminopeptidase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • congenital and developmental bone disorder
    ¼±Ãµ¼º ¹× ¹ßÀ°¼º °ñ Àå¾Ö
  • congenital and developmental muscle disorder
    ¼±Ãµ¼º ¹× ¹ßÀ°¼º ±ÙÀå¾Ö
    Ãâ»ý ½ÃºÎÅÍ ±ÙÀúÇϸ¦ ³ªÅ¸³»°í Èå´ÃÈå´ÃÇÑ ¾ÆÀÌ. flo
  • congenital muscle disorder
    ¼±Ãµ¼º ±Ù Àå¾Ö
  • conversion disorder
    Àüȯ Àå¾Ö
    1. ±âÁúÀû ÁúȯÀÌ ¾øÀÌ ¹«ÀǽÄÀûÀÎ ¿ä±¸³ª °¥µîÀ¸·Î ÀÎÇÑ °¨°¢À̳ª ¿îµ¿ ±â´ÉÀÇ Àå¾Ö°¡ Ư¡ÀÎ Á¤½Å Áúȯ. 2. ½Å°æÇÐÀû ¶Ç´Â ³»°úÀû ÁúȯÀÌ ¾øÀÌ ¸¶ºñ, ½Ã·Â »ó½Ç, ÇÔ±¸Áõ
  • craniocervical disorder
    µÎ°æºÎ Àå¾Ö
  • craniofacial disorder
    µÎ°³ ¾È¸é Àå¾Ö
  • dependent personality disorder
    ÀÇÁ¸¼º ÀÎ°Ý Àå¾Ö
  • depersonalization disorder
    ÀÌÀÎ Àå¾Ö
    ºñÇö½ÇÀûÀÎ ´À³¦À̳ª ÀÚ±âÀڽŠ¶Ç´Â Àڱ⠽Åü»ó¿¡ ´ëÇÑ ÀÌ»óÇÑ ´À³¦ µîÀÇ ÀÌÀÎÁõÀÌ ÇÑ ¹ø ¶Ç´Â ±× ÀÌ»ó ÀÖ¾úÀ¸¸ç, ÀÌ·± Áõ»óµéÀÌ Á¤½ÅºÐ¿­Áõ °°Àº ´Ù¸¥ Á¤½ÅÀå¾Ö·Î ÀÎÇÑ °ÍÀÌ ¾Æ´Ñ Á¤½ÅÀå¾ÖÀÇ ÀÏÁ¾. ÀÌÀÎÁõÀº Çö±â, ºÒ¾È, ±¤±â¿¡ ´ëÇÑ °øÆ÷¿Í ºñÇö½Ç°¨ µîÀÌ ÈçÈ÷ µ¿¹ÝµÈ´Ù. ÀÌÀνŰæÁõ ¶Ç´Â ÀÌÀÎÁõÈĶó°íµµ ºÎ¸¥´Ù.
  • development disorder
    ¹ßÀ° Àå¾Ö
  • developmental disorder
    ¹ß´Þ Àå¾Ö, ¹ßÀ° Àå¾Ö
    acquired disorder, congenital disorder¸¦ º¸½Ã¿À.
  • devlopmental disorder
    ¹ßÀ° ÀÌ»ó
  • disc interference disorder
    °üÀý¿øÆÇ Àå¾Ö
    disc dis
  • disc-interference disorder
    °üÀý¿øÆÇ Àå¾Ö
  • disorder
    Àå¾Ö, ÀÌ»ó, Áúº´
    ±â´É, ±¸Á¶ ¶Ç´Â Á¤½Å »óÅÂÀÇ ÀÌ»ó.
  • disorder of blood platelet
    Ç÷¼ÒÆÇ Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
placental transfusion Return to the newborn via the umbilical vessels some of the foetal placental blood.
(05 Mar 2000)
purified placental protein human placental lactogen
dystocia, placental Trouble delivering the placenta (the afterbirth).
(12 Dec 1998)
trophoblastic tumour, placental site A tumour that arises from the trophoblast of the placental bed and is composed mainly of cytotrophoblastic cells. It encompasses lesions of low- and high-grade malignancy. (holland et al., cancer medicine, 3d ed, p1691)
(12 Dec 1998)
affective personality disorder A disturbance of feelings or mood expressed as a milder form of depression and related emotional features that colour the whole psychic life and for which psychosocial stressors are believed to play the major role.
(05 Mar 2000)
alcohol amnestic disorder <psychiatry> A mental disorder with brain damage characterised by amnesia, compensatory confabulation, disturbance of attention, and peripheral neuritis. It is usually associated with alcoholism and dietary deficiencies.
(12 Dec 1998)
antisocial personality disorder <psychiatry> An individual who engages in deviant behaviour with lack of remorse.
(13 Jan 1998)
asthenic personality disorder A personality type characterised by low energy level, easy fatigability, incapacity for enjoyment, lack of enthusiasm, and oversensitivity to physical and emotional stress. When appearing in marked form it becomes a psychological disorder (asthenic personality disorder), also called dependent personality.
Synonym: asthenic personality disorder, dependent personality disorder.
(05 Mar 2000)
attention deficit disorder An inability to control behaviour due to difficulty in processing neural stimuli.
(12 Dec 1998)
attention deficit disorder with hyperactivity A behaviour disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood.
(12 Dec 1998)
attention deficit hyperactivity disorder <psychiatry> A condition seen in children where there is increased motor activity in association with poor attention span. Often treated with amphetamine medications.
(27 Sep 1997)
autistic disorder autism, infantile autism
autonomic disorder Disorganization of autonomic processes.
(05 Mar 2000)
avoidant disorder of adolescence A mental disorder occurring in childhood or adolescence characterised by an excessive shrinking away from contact with people who are unfamiliar.
Synonym: avoidant disorder of adolescence.
(05 Mar 2000)
avoidant disorder of childhood A mental disorder occurring in childhood or adolescence characterised by an excessive shrinking away from contact with people who are unfamiliar.
Synonym: avoidant disorder of adolescence.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á